This suggests loss of several features of glioblastoma aggressiveness in BTL3 probably based on lower EGFR-mediated signals (Aghi et al, 2005; Kang et al, 2005; Lamszus et al, 2005). The gene discussed is EGFR; the disease is glioblastoma.